Guardian Pharmacy Services, Inc. income statement GRDN

Annual Quarterly

In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, Guardian Pharmacy Services, Inc. reported revenue of $371.1 million, down 1.7% from the same quarter a year earlier. Net income was $18.7 million, a profit margin of 5.0%. Operating income came to $25.1 million, an operating margin of 6.8%. Diluted earnings per share were $0.29.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the same quarter a year earlier.

Line	TTM Sep 30, 2026	Q3 FY2026 Sep 30, 2026	Q2 FY2026 Jun 30, 2026	Q1 FY2026 Mar 31, 2026	Q4 FY2025 Dec 31, 2025	Q3 FY2025 Sep 30, 2025	Q2 FY2025 Jun 30, 2025	Q1 FY2025 Mar 31, 2025	Q3 FY2024 Sep 30, 2024
Revenue	1,457	371 -1.7%	352 +2.2%	337 +2.2%	398	377 +20.0%	344	329	314
Cost of revenue	1,130	286 -5.6%	272 -1.6%	260 -1.8%	312	303 +19.4%	276	265	254
Gross profit	327	85 +14.1%	80 +17.5%	76 +18.6%	86	75 +22.7%	68	64	61
Selling, general and administrative	233	60 +3.1%	59 +6.9%	59 +14.2%	55	58 -64.7%	56	51	165
Operating expenses	233	60 +3.1%	59 +6.9%	59 +14.2%	55	58 -64.7%	56	51	165
Operating income	94	25 +53.3%	21 +64.1%	18 +35.9%	31	16 +115.6%	13	13	-105
Interest expense	1	0 +10.6%	0 -10.5%	0 -9.4%	0	0 -84.4%	0	0	1
Other non-operating income (expense)	12	1 +149.7%	9 +5096.6%	1 +184.9%	0	0 +21950.0%	0	0	-0
Pretax income	105	26 +56.2%	30 +136.7%	18 +39.6%	31	17 +115.7%	13	13	-106
Income tax	29	7 -2.6%	8 +104.0%	5 +23.9%	10	7 +3898.9%	4	4	0
Net income	75	19 +90.3%	22 +142.2%	13 +40.7%	21	10 +108.0%	9	9	-122
Basic EPS	—	0.29	—	—	—	—	—	—	—
Diluted EPS	—	0.29	—	—	—	—	—	—	—
Weighted average shares, basic	—	63	—	—	—	—	—	—	—
Weighted average shares, diluted	—	64	—	—	—	—	—	—	—
Other measures
Depreciation and amortization	23	6 +1.6%	6 +5.8%	6 +13.5%	6	6 -60.1%	5	5	15
EBITDA	118	31 +39.7%	26 +46.4%	24 +29.4%	37	22 +124.7%	18	18	-90
Interest coverage	145.28x	141.60x	134.05x	114.77x	188.72x	102.21x	73.14x	76.50x	-101.96x
Margins
Gross margin	22.45%	22.97%	22.75%	22.67%	21.50%	19.80%	19.79%	19.54%	19.36%
Operating margin	6.46%	6.75%	5.87%	5.25%	7.74%	4.33%	3.65%	3.95%	-33.27%
Pretax margin	7.22%	7.00%	8.47%	5.43%	7.82%	4.41%	3.66%	3.98%	-33.60%
Profit margin	5.13%	5.03%	6.22%	3.95%	5.26%	2.60%	2.62%	2.87%	-38.80%
EBITDA margin	8.07%	8.35%	7.52%	7.03%	9.18%	5.88%	5.25%	5.55%	-28.62%
Effective tax rate	27.68%	26.40%	25.75%	25.96%	31.62%	42.32%	29.87%	29.25%	—

How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

New to this? Read How to Read an Income Statement, With a Real Example.

Company profile

Industry: Retail-Drug Stores and Proprietary Stores (SIC 5912)
Listed as: GRDN (NYSE)
Fiscal year ends: December 31
Incorporated in: GA
Headquarters: Atlanta, GA
SEC filer status: Accelerated filer
SEC CIK: 1802255
Former names: Guardian Pharmacy Services, Inc. (until Nov 5, 2026); Guardian Pharmacy, LLC (until Jul 23, 2021)

Other Retail-Drug Stores and Proprietary Stores companies

All 6 Retail-Drug Stores and Proprietary Stores companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.